000 01580 a2200457 4500
005 20250517102543.0
264 0 _c20180102
008 201801s 0 0 eng d
022 _a1573-2509
024 7 _a10.1016/j.schres.2016.06.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCox, David A
245 0 0 _aProteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
_h[electronic resource]
260 _bSchizophrenia research
_c11 2016
300 _a98-107 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aChromatography, Liquid
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aKetamine
650 0 4 _aMachine Learning
650 0 4 _aMale
650 0 4 _aMice, Transgenic
650 0 4 _aPhencyclidine
650 0 4 _aPrefrontal Cortex
_xmetabolism
650 0 4 _aProtein Interaction Maps
650 0 4 _aProteomics
650 0 4 _aPsychotic Disorders
_xmetabolism
650 0 4 _aRats
650 0 4 _aReceptors, N-Methyl-D-Aspartate
_xdeficiency
650 0 4 _aSchizophrenia
_xmetabolism
650 0 4 _aTandem Mass Spectrometry
700 1 _aGottschalk, Michael G
700 1 _aWesseling, Hendrik
700 1 _aErnst, Agnes
700 1 _aCooper, Jason D
700 1 _aBahn, Sabine
773 0 _tSchizophrenia research
_gvol. 177
_gno. 1-3
_gp. 98-107
856 4 0 _uhttps://doi.org/10.1016/j.schres.2016.06.012
_zAvailable from publisher's website
999 _c26153173
_d26153173